According to the Breast Cancer Information Core (BIC) database [8,9], about two thirds of germline variants identified in BRCA1 and BRCA2 are unique; the remaining ones are recurrent founder mutations which have been described in different ethnic groups and populations. This evidence concerns the gene BRCA2 and breast cancer.